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A Pathogenetic Role for TNFa in the Syndrome
of Cachexia, Arthritis, and Autoimmunity
Resulting from Tristetraprolin (TTP) Deficiency
Gregory A. Taylor,1, 6 Ester Carballo,1, 6 1989, 1991), is a widely distributed 33.6 kDa phospho-
protein encoded by the immediate±early response gene,David M. Lee,2 Wi S. Lai,1
Michael J. Thompson,1 Dhavalkumar D. Patel,2 Zfp-36 (Taylor et al., 1991). This gene has been mapped
to chromosome 7 in the mouse, and the equivalent hu-Daniel I. Schenkman,4 Gary S. Gilkeson,3
Hal E. Broxmeyer,5 Barton F. Haynes,2 man gene, ZFP36, has been mapped to chromosome
19q 13.1 (Taylor et al., 1991). TTP is the prototype of aand Perry J. Blackshear1
1Howard Hughes Medical Institute Laboratory group of proteins containing two or more highly con-
served putative zinc fingers of the CCCH class (Varnumand the Section of Diabetes and Metabolism
Division of Endocrinology, Metabolism and Nutrition et al., 1991; Taylor et al., 1991; Gomperts et al., 1990;
Ma et al., 1994; Thompson et al., 1996). In addition, theDepartments of Medicine and Biochemistry
and the Sarah W. Stedman Center for Nutritional Studies protein has been shown to bind Zn21 and has been
2Division of Rheumatology, Allergy, localized to the cell nucleus in mouse fibroblasts (Du-
and Clinical Immunology Bois et al., 1990), suggesting that it may be a transcrip-
Department of Medicine tion factor. Serum or other mitogen stimulation of quies-
Duke University Medical Center cent fibroblasts causes rapid serine phosphorylation
Durham, North Carolina 27710 and nuclear to cytosolic translocation of TTP (Taylor et
3Medical Research Service al., 1995, 1996), both of which are likely to modulate its
Durham Veterans' Administration Medical Center function in cells.
Durham, North Carolina 27705 In the adult mouse, TTP mRNA is highly expressed in
4Division of Laboratory Animal Resources lung, intestine, lymph node, spleen, and thymus, with
and the Department of Pathology lower expression in adipose tissue, kidney, and liver,
Duke University Medical Center and negligible expression in skeletal muscle and brain
Durham, North Carolina 27705 (Lai et al., 1990; DuBois et al., 1990). In the thymus, TTP
5Department of Medicine (Hematology/Oncology) mRNA is highly expressed in both cortical and medullary
Microbiology/Immunology and the Walther Oncology thymocytes, while in the spleen, it is highly expressed
Center in B and T lymphocytes within the white pulp, and is
Indiana University School of Medicine expressed at somewhat lower levels in the myeloid cells
Indianapolis, Indiana 46202-5121 of the red pulp and endothelial cells of the high endothe-
lial venules. In addition, TTP is constitutively expressed
in several types of blood cells, particularly neutrophils,
macrophages, and B and T lymphocytes (W. S. Young,Summary
III, W. S. L., G. A. T., and P. J. B., unpublished data).
However, its function in normal vertebrate physiologyTristetraprolin (TTP) is a widely expressed potential
is unknown.transcription factor that contains two unusual CCCH
To investigate the physiological role of TTP in intactzinc fingers and is encoded by the immediate±early
animals, we generated TTP-deficient mice by using generesponse gene, Zfp-36. Mice made deficient in TTP
targeting in murine embryonic stem (ES) cells. Theseby gene targeting appeared normal at birth, but soon
mice appeared normal at birth, but within 1±8 weeksmanifested marked medullary and extramedullary my-
after birth they developed patchy alopecia, dermatitis,eloid hyperplasia associated with cachexia, erosive
erosive arthritis, cachexia, conjunctivitis, myeloid hyper-arthritis, dermatitis, conjunctivitis, glomerular mesan-
plasia, glomerular mesangial thickening, and antinucleargial thickening, and high titers of anti-DNA and antinu-
antibodies. Virtually all aspects of the phenotype couldclear antibodies. Myeloid progenitors from these mice
be prevented by injecting the mice with a monoclonalshowed no increase in sensitivity to growth factors.
antibody (MAb) capable of neutralizing tumor necrosisTreatment of young TTP-deficient mice with antibod-
factor a (TNFa). These studies identify TTP as a modula-ies to tumor necrosis factor a (TNFa) prevented the
tor of TNFa production, turnover, or action in vivo. Indevelopment of essentially all aspects of the pheno-
addition, they suggest that the TTP-deficient mice maytype. These results indicate a role for TTP in regulating
prove to be valuable models of human autoimmune dis-TNFa synthesis, secretion, turnover, or action. TTP-
orders, such as rheumatoid arthritis and systemic lupusdeficient mice may serve as useful models of the auto-
erythematosus, and the role that TNFa plays in theimmune inflammatory state resulting from chronic ef-
fective TNFa excess. pathogenesis of such disorders.
Introduction
Results
Tristetraprolin (TTP) (Lai et al., 1990), also known as
Generation of TTP (2/2) MiceNup475 (DuBois et al., 1990) and TIS11 (Varnum et al.,
A targeting vector was constructed that contained 3.8
kb of the gene encoding TTP, Zfp-36 (Taylor et al., 1991),
in which a neomycin resistance gene (neo) was inserted6 The first two authors contributed equally to this work.
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Figure 2. Growth Curves of Two (2/2) and Three (1/1) or (1/2)
Littermates
Weekly weights of one litter of five pups are shown; genotypes of
each mouse are indicated to the right of the figure.
were heterozygous (1/2), and 99 (20%) were homozy-
gous null (2/2), indicating that there was no substantial
embryonic lethality associated with the (2/2) genotype.
Northern analysis of tissues from (1/2) mice revealed
that the endogenous TTP mRNA signal was decreased
by about 50%, and that a TTP±neo fusion mRNA had
been generated (Figure 1A). No endogenous TTP mRNA
was detected in tissues from a (2/2) mouse, but the
TTP±neo fusion mRNA signal was increased over that
seen in the (1/2) mice. Because the neo portion of
the TTP±neo fusion mRNA contains many termination
codons, a complete TTP±neo translation product should
not be made; however, translation of an amino-terminal
TTP fragment could conceivably have occurred. To test
Figure 1. Expression of TTP mRNA and Protein this possibility, primary embryonic fibroblasts were gen-
(A) Total RNA was isolated from the indicated tissues of (1/1), erated from both (1/2) and (2/2) embryos, and immu-
(1/2), and (2/2) mice and subjected to Northern blotting with a noprecipitations were performed on lysates from these
TTP cDNA probe. Each lane contains 15 mg of total cellular RNA.
cells, using an antibody (Taylor et al., 1995) directed atThe lower band represents endogenous TTP mRNA, whereas the
the amino terminus of TTP (Figure 1B). Although TTPupper band represents the TTP±neo fusion RNA.
was readily detectable in (1/2) cells, neither intact TTP(B) Primary embryonic fibroblasts were isolated from three different
(1/2) (A±C) and three different (2/2) (D±F) embryos. The cells were nor a truncated amino-terminal TTP fragment could be
serum deprived for 24 hr, and then exposed to [35S]cysteine for 2 detected in the (2/2) cells (Figure 1B).
hr and 20% fetal calf serum for an additional 2 hr. Lysates from The expression of two other mRNAs that encode re-
these cells were used for immunoprecipitation with an antibody that
lated CCCH zinc finger proteins was also measured torecognizes the amino terminus of TTP, and the immunoprecipitated
determine whether their expression was compensatorilyproteins were separated on a 9% acrylamide SDS gel. An autoradio-
increased in TTP-deficient mice; however, no change ingraph of this gel is shown here. The positions of molecular mass
standards are indicated. TTP migrates at about 43 kDa. Immunopre- expression of either TIS11B (cMG1) (Varnum et al., 1989;
cipitated proteins from the same samples were also separated on Taylor et al., 1991) or TIS11D (Varnum et al., 1991) was
a 20% acrylamide SDS gel (data not shown); no truncated amino- noted (data not shown).
terminal TTP fragment was detected in the (2/2) samples.
Histological Characteristics of TTP (2/2) Mic
The (2/2) mice appeared normal at birth, but their rateinto the protein-coding portion of the second exon. In-
sertion of this sequence introduced multiple stop co- of weight gain began to decrease compared with lit-
termates between 1±8 weeks after birth (Figure 2). Thisdons upstream of the sequences encoding the two
putative zinc fingers, precluding synthesis of functional failure of weight gain and eventual cachexia was one of
the most striking characteristics of the phenotype, andTTP protein. Using this targeting vector and estab-
lished experimental methods (Koller and Smithies, occurred in essentially all of the mice to varying degrees
(Figure 2). They also developed patchy alopecia, derma-1989), TTP-deficient mice were generated. Among the
first 492 offspring of heterozygous (1/2) crosses, 126 titis, arthritis, and conjunctivitis. Although all (2/2) mice
eventually developed thesyndrome, thedegree towhich(26%) were homozygous wild type (1/1), 267 (54%)
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Figure 3. Calvarial Skin
(A) and (B) are sections through calvarial skin of 7-month-old (1/1)
and (2/2) littermate mice, respectively, stained with hematoxylin
and eosin. Note the thickened epidermis (E), the inflammatory infil-
trate in the dermis (D), and the absent subcutaneous fat (F) layer in
the (2/2) mouse. Scale bar, 0.5 mm. Figure 4. Histological Sections of Proximal Interphalangeal Joints
Tissue sections from 7-month-old (1/1) and (2/2) male littermate
mice were stained with hematoxylin and eosin.they were affected was variable. 34% (of 56) were se- (A) and (B) are sections through a proximal interphalangeal joint
verely affected and died before reaching 7 months of from one (1/1) littermate mouse and one (2/2) littermate mouse,
age. The remaining (2/2) mice were less severely af- respectively. Note that in the (2/2) section, the inflamed synovium
or pannus (P) is beginning to protrude into the joint space, whilefected, but nevertheless, 68% (of 37) displayed derma-
the marrow cavity (M) is full of myeloid cells compared with thetitis, 88% displayed arthritis, and 72% displayed con-
essentially empty marrow cavity from the (1/1) mouse. Scale bar,junctivitis by 7 months of age. At the time of this writing,
0.5 mm.the longest survival of a (2/2) mouse was 16 months.
Histological examination of the (2/2) mice demon-
strated several characteristic abnormalities. In the skin The epidermis of the eyelid was also thickened, as
was the palpebral conjunctiva. Neutrophils infiltratedof 7-month-old littermate mice (Figures3A and 3B), there
was orthokeratotic hyperkeratosis in many areas, with the dermis beneath both the eyelid and the conjunctiva
(data not shown). In addition, there were relatively fewan infiltration of neutrophils in the epidermis, and
marked acanthosis. There was also diffuse inflammation mucous cells along the surface of the conjunctiva in the
(2/2) mice.in the underlying dermis, characterized by accumulation
of many neutrophils and fewer lymphocytes, plasma In most joints in both the front and rear paws of the
(2/2) mice at 7 months of age (Figures 4 and 5), thecells, and macrophages. The inflammatory infiltrates ex-
tended to the deep dermal margins of the tissue and, synovium was markedly inflamed and thickened, with
proliferating synovial cells extending well into the jointin some cases, to the underlying skeletal muscle. Large
numbers of Gr-11 neutrophils were present in both the spaces; the synovium contained many Mac-11 macro-
phages and fewer Gr-11 neutrophils, CD31, TCRab1, andepidermis and the dermis, while small foci of CD31,
TCRab1, and Thy1.21 lymphocytes, 75% of which were Thy1.21 lymphocytes and plasma cells (data not shown).
In addition, there was apparent proliferation of synovialof the CD41 subset, were also present in thedermis (data
not shown). A striking finding was that subcutaneous fat cells and pannus formation, which in some cases com-
pletely separated apposing joint surfaces (Figure 5). Ero-was essentially absent (Figure 3), as was mesenteric
and epididymal fat. sion of articular cartilage by pannus and extensive bone
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Figure 5. Histological Sections of Carpal Joints
Figure 6. Wright Staining of a Cytopreparation of Femoral BoneTissue sections from the carpal region of 7-month-old male lit-
Marrowtermate mice stained with hematoxylin and eosin are shown; (A) is
Femoral bone marrow from (A) (1/1) and (B) (2/2) 6-month-oldfrom a (1/1) mouse and (B) is from a (2/2) mouse. Note that in
female littermate mice was isolated and stained with Wright stain.the (2/2) section, the inflamed synovium or pannus (P) protrudes
Note the increase in number of mature granulocytes in the marrowbetween the radial head (RH) and the carpal bones (C), the bone
from the (2/2) mouse. Scale bar, 0.05 mm.marrow (M) cavity is greatly expanded, and the radial head has been
eroded by the inflamed synovium and by expansion of the bone
marrow cavity (arrow). Scale bar, 0.5 mm.
of necrotizing hepatitis were present that contained a
mixed inflammatory exudate of neutrophils, macro-
phages, and lymphocytes (data not shown). There wasdestruction were common (Figure 5). The marrow cavit-
ies were densely filled with cells of the myeloid lineage, also an inflammatory abscess in the interventricular sep-
tum of one mouse (data not shown).especially mature neutrophils, and there was marked
osteolysis of the inner aspect of the cortical bones (see Because antinuclear antibodies were present (see be-
low), the kidneys were examined histologically by stain-Figure 4; Figure 5).
Several abnormalities were also noted in the hemato- ing with hemotoxylin and eosin, periodic acid Schiff,
and Congo red, and immunologically, for the presencepoietic systems of the (2/2) mice. The thymuses in adult
(2/2) mice were hypoplastic and showed no cortical/ and absence of immunoglobulin G (IgG) and IgM. The
tubular and interstitial architecture was essentially nor-medullary organization; the thymuses of 4 days postpar-
tum (2/2) mice were decreased in size by an average mal in the kidneys from the (2/2) mice, but the glomeruli
manifested increased cellularity and increased periodicof 50%. Spleens of the (2/2) mice were enlarged by an
average of 41%, and there was extensive splenic my- acid Schiff±positive mesangial matrix (data not shown).
There was also focal segmental thickening of peripheraleloid hyperplasia, with many metamyelocytes, bands,
and segmented neutrophils present. The perirenal, sub- capillary loops, which were congested with erythro-
cytes. IgG and IgM staining of glomeruli were similar inmaxillary, and mesenteric lymph nodes were also often
enlarged, again showing extensive extramedullary he- the kidneys from the (1/1) and (2/2) mice. Proteinuria
was not increased in the (2/2) mice compared withmatopoiesis, primarily granulopoiesis. There was a
marked increase in the number of myeloid cells in the control, nor were plasma BUN and creatine significantly
elevated compared with control (data not shown).bone marrow (Figure 6), which appeared nearly white in
contrast with the red marrow of the control animals.
Essentially all of the marrow myeloid cells were strongly Hematopoietic Cell Populations in TTP (2/2) Mice
To characterize further the hematopoietic abnormalitiesGr-11 (data not shown). Although the cellular architec-
ture of the liver appeared normal in (2/2) mice, foci seen in the (2/2) mice, complete blood counts and flow
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Figure 7. Flow Cytometric Analysis of Gr-11
Neutrophils, Ly-51 B Lymphocytes, Thy-11 T
Lymphocytes, and F4/801 Monocytes/Mac-
rophages in Peripheral Blood of Adult (1/1)
and (2/2) Mice
Cell surface analysis was performed using a
Becton Dickinson FACStar Plus flow cyto-
meter and the accompanying software.
Shown are the results from representative
mice. The average percent positive cells and
average absolute number of positive cells per
mm3 (6 SEM) from 5±7 adult mice were the
following:
(A) Gr-1: (1/1) 23% 6 4%, 1.13 6 0.27 3 103;
(2/2) 48% 6 2%, 4.36 6 0.72 3 103.
(B) Ly-5: (1/1) 26% 6 3%, 1.36 6 0.28 3 103;
(2/2) 6% 6 1%, 0.71 6 0.15 3 103.
(C) Thy-1: (1/1) 33% 6 6%, 1.67 6 0.53 3
103; (2/2) 33% 6 3%, 3.41 6 0.39 3 103.
(D) F4/80: (1/1) 5% 6 1%, 0.29 6 0.05 3 103;
(2/2) 8% 6 2%, 0.87 6 0.26 3 103.
Similar analyses from spleen and bone mar-
row are discussed in the text.
cytometric analyses of leukocyte subsets were per- and peripheral blood were unchanged (data not shown).
Erythroid burst-forming units (E-BFU) and multipoten-formed (Figure 7; data not shown). In the (2/2) mice,
the total peripheral white blood cell count was elevated tial granulocyte±erythrocyte±macrophage±megakaryo-
cyte (GEMM-CFU) progenitors per spleen, femur, andby more than 2-fold (10.5 6 1.3 [SEM] 3 103 [n 5 7] per
mm3 versus 5.0 6 0.8 3 103 [n 5 6] per mm3). There was milliliter of peripheral blood were not significantly differ-
ent (p > 0.05) in the young (2/2) and (1/1) mice (dataa marked increase in myeloid cells, with sharp increases
in the number of Gr-11 neutrophils and F4/801 macro- not shown). In the older mice, there were marked in-
creases in myeloid progenitors (GM-CFU, E-BFU, andphages in peripheral blood and spleen, and in the num-
ber of Gr-11 neutrophils in bone marrow. The marrow GEMM-CFU) in spleen and peripheral blood but not
bone marrow from the (2/2) compared with (1/1) mice.myeloid cells were karyotypically normal, suggesting
(but not proving) that they had not undergone malignant Comparative progenitor cell values 3 103 per spleen
(2/2 versus 1/1) were 145 6 50 versus 6 6 5 for GM-transformation. There were also increases in the number
of PK1361 natural killer cells in both peripheral blood CFU, 115 6 51 versus 7 6 4 for E-BFU, and 10 6 4
versus 0.2 6 2 for GEMM-CFU. Comparative values perand spleen. Conversely, there were smaller and less
consistent decreases in B and T (B220) lymphocyte per- milliliter of blood were 1530 6 781 versus 46 6 39 for
GM-CFU, 417 6 273 versus 30 6 27 for E-BFU, andcentages and absolute numbers in hematopoietic tis-
sues. Ly-51 B lymphocytes were decreased inperipheral 62 6 32 versus 4 6 4 for GEMM-CFU. Colonies from
young or old (2/2) or (1/1) mice did not form in vitroblood, but were normal in spleen. The number of Thy-11
T lymphocytes in peripheral blood and spleen was nor- without addition of growth factors, and no obvious dif-
ferences in sensitivity of progenitor cells to stimulationmal, but the number of Thy-11 cells in bone marrow was
decreased by 2-fold. The peripheral red blood cell count, of proliferation by single or multiple cytokines was ap-
parent with bone marrow cells from (2/2) versus (1/1)hemoglobin, hematocrit, and platelet count were within
normal ranges; however, the Ter1191 erythroid cells in mice (data not shown).
Routine serum chemistries, including glucose, werebone marrow were decreased in percentage by about
2-fold, presumably secondary to the massive increase within normal limits in the (2/2) mice, except for slightly
decreased albumin and increased total serum globulinof myeloid cells in the bone marrow.
Assays of hematopoietic progenitor cells per organ and b-globulin levels.
were performed on cells from spleen, bone marrow,
and peripheral blood of young (age 33 days) and older Autoantibodies
Rheumatoid factors (both IgG and IgM) and anti-Sm(6.5±12 months) mice. In the young mice, absolute num-
bers of granulocyte±macrophage colony-forming units antibody titers were repeatedly normal in sera from the
(2/2) mice. However, 3 of 4 of the sera from the (2/2)progenitors (GM-CFU) from (2/2) mouse bone marrow
were increased approximately 2-fold compared with mice expressed high titers of antinuclear antibodes, with
a homogeneous pattern; these antibodies were not de-control (1/1 [n 5 3], 30.8 6 3.6 3 103/femur [mean 6
SEM]; 2/2 [n 5 3]: 64.3 6 0.5 3 103/femur, p < 0.0025 tected in 4 of 4 sera from the (1/1) animals. The (2/2)
sera (but not the [1/1] sera) also contained antibodiesusing Student's t test) whereas GM-CFU from spleen
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Figure 8. Effect of TNFa Antibody Injections on Body Weights
As described in the text, TTP (2/2) mice from seven litters (each litter is labeled A±G) were injected at weekly intervals starting on day 10 of
age with either anti-TNF MAbs (AB; open circles) or PBS (closed circles). Body weights were measured at weekly intervals and are shown
here. Littermates of the TTP (1/1) and (1/2) genotypes are indicated by the lines without symbols. TTP (2/2) mice from litters B, C, and D
that were injected with PBS died before completion of the experiments, which consisted of nine weekly injections. The means 6 SEM of the
six antibody-injected animals and the six PBS-injected animals are shown in (H); the normal range (mean 6 SD) from all of the control
littermates (n 5 25) is indicated by the dashed lines in (H). The differences between the AB and PBS means were significant (p < 0.001 using
Student's t test) at each timepoint after 4 weeks.
to double-stranded DNA (dsDNA) (mean 6 SEM of en- strikingly smaller than their wild-type littermates (Fig-
ures 8 and 9). In contrast, five of six mice injected withzyme-linked immunosorbent assay [ELISA] units from
four (2/2) mice was 0.41 6 0.18 compared with 0.06 6 the TNFa antibody maintained essentially identical
growth curves to those of their (1/1) and (1/2) lit-0.02 from four [1/1] mice; p 5 0.11 by Student's t test).
This finding was confirmed by the Crithidia assay (4 of termates (see Figure 8; Figure 9), whereas one exhibited
slight growth retardation (see Figure 8B). The mean body4 [2/2] mice were positive, compared with 0/4 [1/1]
mice). Finally, sera from the (2/2) mice (but not from weights of the six TTP (2/2) mice receiving the TNFa
antibody were in themiddle of thenormal range through-the [1/1] mice) contained high titers of antibodies to
single-stranded DNA (ssDNA) (mean 6 SEM ELISA units out the trial, whereas the mean weights of those receiv-
ing PBS were significantly (p < 0.001) lower than thosefrom four [2/2] mice was 1.49 6 0.30 compared with
0.22 6 0.05 from four [1/1] mice; p 5 0.006 by Student's receiving antibody at all timepoints after week 4 (see
Figure 8H).t test).
The antibody-injected mice also developed none of
the cutaneous or joint stigmata associated with the
TNFa Antibody Treatment (2/2) syndrome (Figure 9). In addition, the (2/2) mice
Because the phenotype of the TTP-deficient mice re- injected with TNFa antibodies did not display medullary
sembled that produced by chronic administration of myeloid hyperplasia, with marrow from these animals
TNFa (Kefferet al., 1991; Ulich et al., 1993),we attempted containing 33.7% 6 3.1% (SEM) mature granulocytes
to prevent the development of the phenotype by treating and bands, compared with 30.4% 6 3.0% for the wild-
the mice beginning at 10 days of age with nine weekly type animals (p 5 .49). To date, every examined aspect
intraperitoneal injections of a hamster MAb (TN3±19.12) of the TTP-deficient phenotype has beenessentially nor-
that is specific for mouse TNFa (Sheehan et al., 1989). malized by the injection of TNFa antibody.
This antibody was originally thought to cross-react with
TNFb (Sheehan et al., 1989); however, subsequent work
has shown that it does not neutralize the biological Discussion
activity of this cytokine (R. D. Schreiber, personal com-
munication). Of six TTP (2/2) mice injected with phos- The phenotype of the (2/2) mice is a complex syndrome
consisting of erosive arthritis, dermatitis, conjunctivitis,phate-buffered saline (PBS), four exhibited striking
growth retardation, and one exhibited mild growth retar- autoimmunity, glomerular mesangial thickening, loss of
adipose tissue, and myeloid hyperplasia. Because thedation (Figure 8A). The sixth PBS-injected mouse died
before growth retardation could become obvious (Figure myeloid hyperplasia predated the other characteristics
of the syndrome, we considered that a primary result8B); two others died before completion of the trial (Figure
8). Three PBS-injected mice survived the trial, but were of TTP deficiency might be unrestrained proliferation or
Tumor Necrosis Factor a in TTP Deficiency
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Figure 9. Effect of TNFa Antibody Injections
Three littermate mice (from litter F in Figure
8) were treated as follows: one (1/1) or wild-
type (WT) mouse received no treatment; one
(2/2) mouse received anti-TNFa antibodies
(KO-Ab); and one (2/2) mouse received PBS
injections alone (KO-PBS). The mouse la-
beled KO-Ab is pictured twice. At the end of
theexperiment, their respective body weights
were the following: WT, 23.2 g; KO-Ab, 23.6
g; KO-PBS, 10.6 g.
differentiation of myeloid cells. Since TTP is a potential these cells argues against the first possibility, and pre-
liminary studies have suggested that apoptosis occurstranscription factor, it might normally serve as a repres-
sor of myeloid cell differentiation or proliferation. normally in the marrow cells of the TTP-deficient mice.
The medullary and extramedullary myeloid hyperpla-However, in vitro cultures of myeloid progenitors from
bone marrow, spleen, and peripheral blood revealed no sia seen in the TTP-deficient mice is similar to that seen
in interleukin-8 receptor-deficient mice (Cacalano et al.,autonomous (i.e., growth factor-independent) myeloid
cell proliferation, and no apparent increase in the sensi- 1994; Broxmeyer et al., 1995, Blood 86 [Suppl.], ab-
stract). However, these mice did not develop cachexia,tivity of myeloid progenitors to a variety of growth fac-
tors. These data suggest that the medullary and extra- arthritis, dermatitis, or conjunctivitis. This indicates that
expansion of the myeloid cell pool alone does not leadmedullary myeloid hyperplasia were unlikely to be the
result of a primary lack of repression of myeloid differen- to invasion of peripheral tissues and the systemic inflam-
matory reaction, as seen in the TTP-deficient mice. Po-tiation or proliferation in the TTP-deficient mice. Instead,
they indicate that the myeloid hyperplasia might be a tential mediators of this systemic response might be
cytokines such as TNFa. Transgenic mice overexpress-secondary result of increased levels of one or more
hematopoietic colony-stimulating factors or cytokines ing TNFa exhibit a phenotype that is strikingly similar
to that of the TTP-deficient mice, including cachexia,in the (2/2) mice.
Arguing against this possibility is that levels of mRNA chronic arthritis, and dermatitis (Keffer et al., 1991). In
addition, mice chronically injected with TNFa exhibitfor granulocyte macrophage±colony-stimulating factor,
granulocyte colony-stimulating factor, and macrophage both medullary and extramedullary myeloid hyperplasia
(Ulich et al., 1993). However, this mechanism initiallycolony-stimulating factor in marrow and spleen were
no different from control (data not shown). A second seemed unlikely because TNFa mRNA levels in spleen,
bone marrow, and liver were found to be normal in thepossibility is that the mice were more susceptible to
chronic infection; against this possibility are the facts TTP-deficient mice, and serum concentrations of TNFa
were undetectable by ELISA (data not shown).that the mice were kept in autoclaved microisolator
cages in a barrier facility, and known immune-deficient Nonetheless, we found that weekly intraperitoneal in-
jections of a hamster MAb to mouse TNFa (Sheehan etmice housed under the same conditions were not af-
fected. Furthermore, treatment of the mice with Septra al., 1989) prevented the development of essentially all
aspects of the phenotype in TTP-deficient mice, includ-(Biocraft Laboratories, Elwood Park, New Jersey) 0.7
mg/mL sulphamethoxazole, and 0.14 mg/mL trimetho- ing the myeloid hyperplasia. The differences between
the mice receiving antibody and those receiving PBSprim in the drinking water for 4 weeks did not prevent the
onset or progression of the cachexia and inflammatory were most striking and readily appreciated in the curves
of body weight, as well as in the fact that 3 of 6 oflesions. Other potential pathophysiological mechanisms
for the (2/2) phenotype include transformation of the the the PBS-injected mice died during the 9 week trial,
whereas none of the antibody-injected mice died. Theproliferating myeloid cells, or inhibition of apoptosis in
these cells. The normal karyotype and DNA content of antibody injection also prevented the development of
Immunity
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HindIII TTP gene fragment (Taylor et al., 1991). Using this strategy,the characteristic skin and joint lesions. These striking
the 7.5 kB EcoRI fragment that resulted from a targeted TTP alleleresults suggest that essentially all aspects of the ob-
was easily distinguishable from the 10 kb EcoRI fragment that re-served complex phenotype were the consequences of
sulted from a wild-type TTP allele.
chronic excess TNFa circulating in the blood or, con- Cell labeling and immunoprecipitation protocols have been de-
ceivably, increased tissue sensitivity to normal concen- scribed in detail elsewhere (Taylor et al., 1995). In bief, confluent 60
mm plates of cells were serum deprived for 24 hr in DMEM (Hazletontrations of TNFa. The tissue(s) of origin of the TNFa, and
Research Systems, St. Lynexa, Kansas) supplemented with 1%the potential role of TTP in the regulation of its normal
(w/v) bovine serum albumin (Sigma, St. Louis, Missouri), and thensynthesis, secretion, turnover,or action, are the subjects
exposed to [35S]cysteine (DuPont/NEN, Wilmington, Delaware) for 2of ongoing study.
hr and 20% (v/v) fetal calf serum for an additional 2 hr. Next, the
The arthritis seen in the TTP-deficient mice resembles cells were lysed by brief sonication in a buffer containing 1% (w/v)
inflammatory synovitis in humans. Although rheumatoid nonidet P-40, 5 mM EDTA, 0.15 M NaCl, and 50 mM Tris (pH 8.3);
protein was precipitated with an immunopurified polyclonal antise-factor concentrations were normal in these mice, the
rum that recognized the 24 amino-terminal amino acids of TTP (Tay-patterns of joint involvement (interphalangeal, metacar-
lor et al., 1995). Precipitated proteins were separated on 9% or 20%pophalangeal, and carpal joints of the front and rear feet)
polyacrylamide SDS gels, which were dried and used for autoradiog-combined with synovial lining cell proliferation, pannus
raphy.
formation, and cartilage and bone erosion are similar to
those seen in human rheumatoid arthritis (Rosenberg, Myeloid Progenitor Cell Assays
1994). On the other hand, the antinuclear and anti- Assays were performed on femoral bone marrow, peripheral blood,
and spleen from (1/1) and (2/2) mice at 33 days of age (youngssDNA and dsDNA autoantibodies found in the serum of
mice) or 6.5±12 months of age (adult mice). These were performedthe TTP-deficient mice are more characteristic of other
as described (Cooper et al., 1994). Marrow, spleen, and blood cellsautoimmune disorders such as systemic lupus erythe-
were plated at concentrations of 2.5 3 104, 2.5 3 105, and 1.0 3 105
matosus (Theofilopoulos and Dixon, 1985). These mice cells/ml, respectively, in 1.0% methylcellulose culture medium with
may, therefore, ultimately prove to be a valuable model 30% fetal bovine serum (Hyclone,Logan, Utah), 0.1 mM hemin (East-
of one or more human autoimmune diseases. They may man Kodak, Rochester, New York), 1 U/ml recombinant (r) human
(hu) erythropoietin (Epo, Amgen Corp., Thousand Oaks, California),also prove useful for studying a potential role of TNFa
5% v/v pokeweed mitogen mouse spleen cell±conditioned mediumin the pathogenesis of these disorders. Finally, it is inter-
(PWMSCM), and 50 ng/ml r murine (mu) steel factor (SLF; Immunexesting to speculate that total TTP deficiency in man
Corporation, Seattle, Washington). Colonies were scored after 7
might lead to a similar, presumably lethal syndrome, days incubation at 5% CO2 and lowered (5%) O2. Calculation of
whereas heterozygositymight lead to increased suscep- the absolute numbers of progenitors per organ was based on the
tibility to other genetic and environmental causes of nucleated cellularity and colony counts for GM-CFU, E-BFU, and
GEMM-CFU in each organ for each individually assessed mouse.autoimmune disorders.
Cultures were also set up in methylcellulose or 0.3% agar (10% fetal
bovine serum) in the presence or absence of different concentra-Experimental Procedures
tions of Epo, rmu granulocyte±macrophage colony-stimulating fac-
tor, rhu granulocyte colony-stimulating factor, rhu macrophage col-Generation of TTP-Deficient Mice
ony-stimulating factor (Immunex Corporation), or PWMSCM with orA TTP insertion targeting vector was created by first isolating a 3.8
without rmu SLF or rhu Flt-3 ligand (Immunex Corporation) to assesskb Zfp-36 (TTP genomic) clone from a SV129 library (Stratagene,
the sensitivity of cells to stimulation by single or multiple cytokines.La Jolla, California) using a mouse TTP cDNA probe (Lai et al., 1990);
this fragment was cloned into the SalI site of BS(1) (Stratagene). A
Histological Analysis1.14 kb XhoI±BamHI neo fragment from pMC1PolA (Stratagene) was
Mouse tissues were immersed in Bouin's fixative for 2±4 days, andthen ligated into the TTP SstI site (1 kb downstream of the initiator
then washed for several days in 70 % (v/v) ethanol at room tempera-ATG) in pBS1/TTP. Next, a 4.9 kb SalI TTP±neo fragment from
ture. When required, tissues were decalcified following Bouin's fixa-pBS1/TTP±neo was cloned into the SalI site of pSP73 (Promega,
tion by immersing in 12.5% (w/v) sodium citrate and 25% (v/v) formicMadison, Wisconsin), into which two thymidine kinase genes (ClaI±
acid for 24 hr, rinsing in running water for 24 hr, and then washingBamHI and HindIII±XhoI fragments of pIC19R/MC1±tk) (Mansour et
for several days in 70% ethanol, all at room temperature. Fixedal., 1988) had been cloned previously at the pSP73 ClaI±BamHI and
tissues were then embedded for paraffin sectioning; 5±7 mm sec-HindIII±XhoI sites. This targeting vector was linearized with HindIII
tions were stainedwith hematoxylin and eosin by standardmethods,and electroporated into ES cells, which were then used to generate
then photographed with a Nikon Opiphot-2 photomicroscope andchimeric mice according to established methods (Koller and Smith-
Kodak Ektar 100 film.ies, 1989).
Renal pathology was evaluated at 5 months of age. One kidney
was fixed, embedded in paraffin, and sectioned as described aboveNorthern Blot Analysis
prior to staining with hematoxylin and eosin, Congo red, and periodicDissected tissues were rapidly frozen in liquid nitrogen, pulverized in
acid Schiff (Tse, 1980). The other kidney was quick frozen in OCTliquid nitrogen, and then homogenized in a guanidinium thiocyanate
embedding compound on dry ice, and frozen sections were pre-solution, as described previously (Stumpo et al., 1989). Total cellular
pared for immunofluorescent microscopy using fluorescein-conju-RNA was isolated from the tissue lysate using an established acidic
gated goat anti-mouse IgG or IgM (Sigma) as described (Andrewsphenol extraction procedure (Chomzynski and Sacchi, 1987). RNA
et al., 1994).samples (15 mg)were separated by electrophoresis in 1.2%agarose/
Glomerular disease was graded by a pathologist blinded as toformaldehyde gels and used for Northern blotting (Stumpo et al.,
the genotype of origin of the kidney sections. Scores were deter-1989) with a 32P-labeled mouse cDNA probe (Lai et al., 1990).
mined using a grading system that assigns 0±31 scores for prolifera-
tion, necrosis, crescent formation, vasculitis, and inflammatory infil-Cell Culture and Immunoprecipitation
trate. IgG and IgM deposition were graded 0±31 on the fluorescentPrimary embryonic fibroblasts were prepared (Robertson, 1987)
slides by the same pathologist.from 14±17 day mouse embryos that had been generated from TTP
(1/2) mouse matings. To identify (1/2) and (2/2) cell lines, DNA
was isolated from the cells (Koller and Smithies, 1989), digested with Fluorescence-Activated Cell Sorter Analysis
Peripheral blood cells were obtained by capillary tube bleeding fromEcoRI (GIBCO, Gaithersburg, Maryland), and subjected to Southern
blot analysis (Stumpo et al., 1989) using as a probe a 2.4 kb BstEII± the eye orbit; bone marrow cells were obtained by flushing dissected
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femurs with 2 mL ice-cold RPMI 1640 medium (GIBCO), followed equivalent volume of PBS. The first injection occurred when the
animals were 10 days of age, and continued at weekly intervals forby gentle pipeting to disperse the cells; and splenocytes and thymo-
cytes were obtained by macerating dissected tissues with the a total of nine injections. The first two injections were 125 mg of
antibody in 50 ml PBS, and the last seven injections were 250 mgplunger of a disposable 1 ml syringe in ice-cold RPMI 1640 medium,
and then isolating the cells by density centrifugation (Tse, 1980). of antibody in 100 ml of PBS. One week after the final injection, the
animals were killed with C02, and blood and tissues were harvestedSome peripheral blood and bone marrow cells were stained with
ACCUSTAIN Wright Stain (3WS10, Sigma, St. Louis, Missouri) as for blood counts and histology as described above.
described by the manufacturer.
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